Gary L. Sieckman - Concepedia

Author

Gary L. Sieckman

University of Missouri

Also Known As

G L Sieckman, G Sieckman, G. L. Sieckman, G.L. Sieckman, Gary L Sieckman, Gary L. Sieckman, Gary Sieckman

Publications

Citations

H-Index

Concepts

All Affiliations

University of Missouri Harry S. Truman Memorial Veterans' Hospital Missouri College

About

Gary L. Sieckman is an author at University of Missouri specializing in medicine, pharmacology, and nuclear medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	860
2	Engineering	8	8	382
3	Biochemistry	6	6	340
4	Health Sciences	4	4	312
5	Natural Sciences	4	4	234

Gary L. Sieckman

Publications

Citations

H-Index

Page 1

	Year	Citations
[ <sup>64</sup> Cu-NOTA-8-Aoc-BBN(7-14)NH <sub>2</sub> ] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues Adam Prasanphanich, Prasant Kumar Nanda, Tammy L. Rold, Proceedings of the National Academy of Sciences Molecular BiologyPeptide SciencePositron Emission TomographyTranslational Molecular ImagingAnti-cancer Agent	2007	211
Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells. Timothy J. Hoffman, Hariprasad Gali, Charles J. Smith, PubMed	2003	154
In Vivo Evaluation and Small-Animal PET/CT of a Prostate Cancer Mouse Model Using 64Cu Bombesin Analogs: Side-by-Side Comparison of the CB-TE2A and DOTA Chelation Systems Jered C. Garrison, Tammy L. Rold, Gary L. Sieckman, Journal of Nuclear Medicine	2007	154
Radiochemical Investigations of <sup>99m</sup>Tc−N<sub>3</sub>S-X-BBN[7−14]NH<sub>2</sub>: An in Vitro/in Vivo Structure−Activity Relationship Study Where X = 0-, 3-, 5-, 8-, and 11-Carbon Tethering Moieties Charles J. Smith, Hariprasad Gali, Gary L. Sieckman, Bioconjugate Chemistry	2002	105
Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells Charles J. Smith, Hariprasad Gali, Gary L. Sieckman, Nuclear Medicine and Biology Nuclear MedicineEngineeringMedicineTheranosticsRadiochemical Investigations	2003	100
<sup>99m</sup>Tc-Labeling and in Vivo Studies of a Bombesin Analogue with a Novel Water-Soluble Dithiadiphosphine-Based Bifunctional Chelating Agent Srinivasa Karra, Roger Schibli, Hariprasad Gali, Bioconjugate Chemistry	1999	99
Radiochemical investigations of gastrin-releasing peptide receptor-specific [(99m)Tc(X)(CO)3-Dpr-Ser-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-(NH2)] in PC-3, tumor-bearing, rodent models: syntheses, radiolabeling, and in vitro/in vivo studies where Dpr = 2,3-diaminopropionic acid and X = H2O or P(CH2OH)3. Charles J. Smith, Gary L. Sieckman, Nellie K. Owen, PubMed Bioorganic ChemistryPeptide EngineeringRadiochemical InvestigationsTc ConjugatesPeptide Science	2003	93
Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7–14)NH2], in a prostate tumor xenografted mouse model Stephanie R. Lane, Prasanta Nanda, Tammy L. Rold, Nuclear Medicine and Biology EngineeringBiochemistryMedicineTheranosticsMicropet Imaging	2010	69
Synthesis, Characterization, and Labeling with <sup>99m</sup>Tc/<sup>188</sup>Re of Peptide Conjugates Containing a Dithia-bisphosphine Chelating Agent Hariprasad Gali, Timothy J. Hoffman, Gary L. Sieckman, Bioconjugate Chemistry Medicinal ChemistryDithia-bisphosphine Chelating AgentBiochemistryNatural SciencesDrug Discovery	2001	66
Pm-149 DOTA bombesin analogs for potential radiotherapy Fang Hu, Cathy S. Cutler, Timothy J. Hoffman, Nuclear Medicine and Biology Radiation TherapyMedicinePharmacotherapyPotential RadiotherapyRadiation Oncology	2002	63

Page 1